Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments

Antitrust approvals have been granted by the relevant governing authorities, including the Federal Trade Commission (“FTC”), with respect to the previously announced Pfizer Inc. acquisition of Biohaven Pharmaceutical Holding Company Ltd.; preliminary proxy statement has been filed with…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.